Search

Author/Creator Merks, Johannes H

1. Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial. Issue 8 (August 2018)

Authors:
Bisogno, Gianni; Jenney, Meriel; Bergeron, Christophe; Gallego Melcón, Soledad; Ferrari, Andrea; Oberlin, Odile; Carli, Modesto; Stevens, Michael; Kelsey, Anna; De Paoli, Angela; Gaze, Mark N; Martelli, Helene; Devalck, Christine; Merks, Johannes H; Ben-Arush, Myriam; Glosli, Heidi; Chisholm, Jul...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 8(2018)
Page Start:
1061
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the Netherlands. (18th July 2018)

Authors:
Meulepas, Johanna M; Ronckers, Cécile M; Smets, Anne M J B; Nievelstein, Rutger A J; Gradowska, Patrycja; Lee, Choonsik; Jahnen, Andreas; van Straten, Marcel; de Wit, Marie-Claire Y; Zonnenberg, Bernard; Klein, Willemijn M; Merks, Johannes H; Visser, Otto; van Leeuwen, Flora E; Hauptmann, Michael
Journal:
Journal of the National Cancer Institute
Issue:
Volume 111:Number 3(2019)
Page Start:
256
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Response to Wollschläger, Blettner, and Pokora. (12th April 2019)

Authors:
Meulepas, Johanna M; Ronckers, Cecile M; Smets, Anne M J B; Nievelstein, Rutger A J; Gradowska, Patrycja; Lee, Choonsik; Jahnen, Andreas; van Straten, Marcel; de Wit, Marie-Claire Y; Zonnenberg, Bernard; Klein, Willemijn M; Merks, Johannes H; Visser, Otto; van Leeuwen, Flora E; Hauptmann, Michael
Journal:
Journal of the National Cancer Institute
Issue:
Volume 111:Number 9(2019)
Page Start:
1002
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial. Issue 11 (November 2019)

Authors:
Bisogno, Gianni; De Salvo, Gian Luca; Bergeron, Christophe; Gallego Melcón, Soledad; Merks, Johannes H; Kelsey, Anna; Martelli, Helene; Minard-Colin, Veronique; Orbach, Daniel; Glosli, Heidi; Chisholm, Julia; Casanova, Michela; Zanetti, Ilaria; Devalck, Christine; Ben-Arush, Myriam; Mudry, Peter;...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 11(2019)
Page Start:
1566
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗